| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |